A CLINICAL trial into the benefits and risks of puberty blockers in teenagers is set to proceed after a legal challenge over the trial was thrown out by a High Court judge.
The trial, known as Pathways, is set to see around 220 children with persistent gender incongruence receive puberty suppressing hormones, half of whom would begin the treatment straight away while half would start it a year later.
